NCT04085224View on ClinicalTrials.gov

6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

January 2, 2020

Study Completion Date

January 2, 2020

Conditions
Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers
Interventions
DRUG

Somatropin

LG Somatropin

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

LG Chem
All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT04085224 - 6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers | Biotech Hunter | Biotech Hunter